{"id":936,"date":"2022-12-07T14:46:39","date_gmt":"2022-12-07T05:46:39","guid":{"rendered":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English-test\/?p=936"},"modified":"2024-03-22T14:51:24","modified_gmt":"2024-03-22T05:51:24","slug":"publications-2022","status":"publish","type":"post","link":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/2022\/12\/07\/publications-2022\/","title":{"rendered":"Publications 2022"},"content":{"rendered":"<ol>\n<li class=\"list paragraph\"><u class=\"character\">Ebata T<\/u>,\u00a0<u class=\"character\">Yamashita S<\/u>,\u00a0<u class=\"character\">Takeshima H<\/u>, Yoshida H, Kawata Y, Kino N, Yasugi T, Terao Y, Yonemori K, Kato T and\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>. DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer.\u00a0<strong><em>Gynecol Oncol<\/em><\/strong>, 167: 513-518, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36253303\/\">36253303<\/a><\/li>\n<li class=\"list paragraph\"><u class=\"character\">Ueda S<\/u>,\u00a0<u class=\"character\">Yamashita S<\/u>, Nakajima M, Kumamoto T, Ogawa C,\u00a0<u class=\"character\">Liu YY<\/u>,\u00a0<u class=\"character\">Yamada H<\/u>,\u00a0<u class=\"character\">Kubo E<\/u>,\u00a0<u class=\"character\">Hattori N<\/u>,\u00a0<u class=\"character\">Takeshima H<\/u>,\u00a0<u class=\"character\">Wakabayashi M<\/u>, Iida N, Shiraishi Y, Noguchi M, Sato Y and\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>. A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy.\u00a0<strong><em>Proc Natl Acad Sci USA<\/em><\/strong>, 119: e2123241119, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35895679\/\">35895679<\/a><\/li>\n<li class=\"list paragraph\"><u class=\"character\">Yamada H<\/u>,\u00a0<u class=\"character\">Takeshima H<\/u>, Fujiki R,\u00a0<u class=\"character\">Yamashita S<\/u>, Sekine S, Ando T,\u00a0<u class=\"character\">Hattori N<\/u>, Okabe A, Yoshikawa T, Obama K, Katai H, Kaneda A and\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>. ARID1A loss-of-function induces CpG island methylator phenotype.\u00a0<strong><em>Cancer Lett<\/em><\/strong>, 532: 215587, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35131383\/\">35131383<\/a><\/li>\n<li class=\"list paragraph\"><u class=\"character\">Takeuchi C<\/u>, Sato J,\u00a0<u class=\"character\">Yamashita S<\/u>, Sasaki A, Akahane T, Aoki R, Yamamichi M,\u00a0<u class=\"character\">Liu YY<\/u>, Ito M, Furuta T, Nakajima S, Sakaguchi Y, Takahashi Y, Tsuji Y, Niimi K, Tomida S, Fujishiro M, Yamamichi N and\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>. Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential.\u00a0<strong><em>J Gastroenterol<\/em><\/strong>, 57: 144-155, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35034200\/\">35034200<\/a><\/li>\n<li class=\"list paragraph\"><u class=\"character\">Zhang CD<\/u>,\u00a0<u class=\"character\">Takeshima H<\/u>, Sekine S,\u00a0<u class=\"character\">Yamashita S<\/u>,\u00a0<u class=\"character\">Liu YY<\/u>,\u00a0<u class=\"character\">Hattori N<\/u>, Abe H, Yamashita H,\u00a0<u class=\"character\">Fukuda M<\/u>, Imamura Y, Ushiku T, Katai H, Makino H, Watanabe M, Seto Y and\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation.\u00a0<strong><em>Gastric Cancer<\/em><\/strong>, 25: 336-345, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34557982\/\">34557982<\/a><\/li>\n<li class=\"list paragraph\"><u class=\"character\">Ebata T<\/u>,\u00a0<u class=\"character\">Yamashita S<\/u>,\u00a0<u class=\"character\">Takeshima H<\/u>, Yoshida H, Kawata Y, Kino N, Yasugi T, Terao Y, Yonemori K, Kato T and\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>. DNA methylation marker to estimate ovarian cancer cell fraction.\u00a0<strong><em>Med Oncol<\/em><\/strong>, 39: 78, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35195779\/\">35195779<\/a><\/li>\n<li class=\"list paragraph\">Shimizu T, Sugihara E, Takeshima H, Nobusue H, Yamaguchi R, Yamaguchi-Iwai S, Fukuchi Y, <span style=\"text-decoration: underline\"><strong><span class=\"character\">Ushijima T<\/span><\/strong><\/span>, Muto A and Saya H. Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo.\u00a0<strong><em>Cells<\/em><\/strong>, 11: 3614, 2022. PMID: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36429043\/\">36429043<\/a><\/li>\n<li class=\"list paragraph\">Kojima N, Arai Y, Satomi K, Kubo T, Matsushita Y, Mori T, Matsushita H, <strong><u class=\"character\">Ushijima T<\/u><\/strong>, Yatabe Y, Shibata T, Yonemori K, Ichimura K, Ichikawa H, Kawai A and Yoshida A. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall.\u00a0<strong><em>Mod Pathol<\/em><\/strong>, 35: 1439-1448, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35440765\/\">35440765<\/a><\/li>\n<li class=\"list paragraph\">Satomi K, Takami H, Fukushima S, <u class=\"character\">Yamashita S<\/u>, Matsushita Y, Nakazato Y, Suzuki T, Tanaka S, Mukasa A, Saito N, Kanamori M, Kumabe T, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Yoshimoto K, Tamura K, Maehara T, Sakai K, Sugiyama K, Yokogami K, Takeshima H, Nonaka M, Asai A,\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>, Matsutani M, Nishikawa R and Ichimura K. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.\u00a0<strong><em>Neuro Oncol<\/em><\/strong>, 24: 834-846, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34698864\/\">34698864<\/a><\/li>\n<li class=\"list paragraph\">Motoo I, Nanjo S, Ando T, <u class=\"character\">Yamashita S<\/u>,\u00a0<strong><u class=\"character\">Ushijima T<\/u><\/strong>\u00a0and Yasuda I. Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers.\u00a0<strong><em>Gastric Cancer<\/em><\/strong>, 25: 325-335, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34554345\/\">34554345<\/a><\/li>\n<li class=\"list paragraph\">Kamachi K, Ureshino H, Watanabe T, Yoshida N, Yamamoto Y, Kurahashi Y, Fukuda-Kurahashi Y, Hayashi Y, Hirai H, <u class=\"character\">Yamashita S<\/u>,\u00a0<strong><span style=\"text-decoration: underline\">Ushijima T<\/span><\/strong>, Okada S and Kimura S. Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia.\u00a0<strong><em>Cancer Lett<\/em><\/strong>, 526: 273-283, 2022. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34875342\/\">34875342<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Ebata T,\u00a0Yamashita S,\u00a0Takeshima H, Yoshida H, Kawata Y, Kino N, Yasugi T, Terao Y, Yonemori K, Kato T and\u00a0Ushijima T. DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer.\u00a0Gynecol Oncol, 167: 513-518, 2022. PMID:\u00a036253303 Ueda S,\u00a0Yamashita S, Nakajima M, Kumamoto T, Ogawa C,\u00a0Liu YY,\u00a0Yamada H,\u00a0Kubo E,\u00a0Hattori N,\u00a0Takeshima H,\u00a0Wakabayashi M, Iida N, Shiraishi Y, Noguchi M, Sato Y and\u00a0Ushijima T. A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy.\u00a0Proc Natl Acad Sci USA, 119: e2123241119, 2022. PMID:\u00a035895679 Yamada H,\u00a0Takeshima H, Fujiki R,\u00a0Yamashita S, Sekine S, Ando &#8230;..<\/p>\n","protected":false},"author":26,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-936","post","type-post","status-publish","format-standard","hentry","category-cat-result"],"acf":[],"_links":{"self":[{"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/posts\/936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/comments?post=936"}],"version-history":[{"count":5,"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/posts\/936\/revisions"}],"predecessor-version":[{"id":1034,"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/posts\/936\/revisions\/1034"}],"wp:attachment":[{"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/media?parent=936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/categories?post=936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jupiter.hoshi.ac.jp\/lab\/epigenome-English\/wp-json\/wp\/v2\/tags?post=936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}